Whatever lies ahead for biotech in 2016, we can now look back on a 3-year-long stretch of good times for the industry. Venture groups have used the wave of biotech IPO exits and M&A deals to go back and raise more..

Becton Dickinson's BD Life Sciences segment said recently that its BD Max Enteric Parasite Panel for use on the BD Max system has received US Food and Drug Administration clearance. The BD Max Enteric Panel i..

Sequenom will collaborate with the University Medical Center Hamburg-Eppendorf in Germany to evaluate the clinical utility of a liquid biopsy assay in colorectal cancer, the firm said today. Sequenom is currently ..

Protalix BioTherapeutics said recently it has sold its 40%-share in the collaboration agreement for the marketed Type 1 Gaucher disease treatment ELELYSO™ (taliglucerase alfa) to its commercialization partner Pf..

Recently, private equity firm GHO Capital announced it has acquired DNA Diagnostics Center for €104 million ($118 million). DNA Diagnostics Center (DDC) provides private DNA testing services including biol..

Recently, Wangjian, CEO of BGI disclosed something when participating certain summit: China will built 10 precision medical center, and BGI applied one. Precision medicine is becoming a focus in the inside and ou..

China Finance disclosed on 9th network, 2015 county level public hospitals reform will be promoted in national scale and adding 66 experimental cities. In order to promote the reform, China central government supp..

The Broad Institute today said that the National Heart, Lung, and Blood Institute has awarded it about $40 million to provide large-scale whole-genome sequencing to 20,000 individuals. The project is part of NHLB..

Recently, Agilent Technologies' Dako said that the US Food and Drug Administration has approved the firm's companion diagnostic assay in connection with a simultaneous approval for Merck's non-small lung c..

Over the last six weeks, we’ve seen several announcements by companies trying to lure consumers to learn about their genomes. Something they all have in common: they’re losing money doing it, at least for ..

Allele Biotechnology & Pharmaceuticals recently announced it has formed a commercial business to bank human induced pluripotent stem cells by private individuals. The San Diego-based firm said that in additi..

Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the rights of use for the HiSeq X Sequencing System to allow customers to perform whole-genome sequencing of non-human species. The updated rights of use w..

1¡¢Jeffrey Immelt Jeffrey Immelt£¬chairman and CEO of GE His income is 37.30 million usd in 2014 2¡¢Alex Gorsky Alex Gorsky£¬chairman and CEO of J&J His income is 24.90 million usd in 2014 3¡¢Inge ..

Thermo Fisher Scientific announced after the close of the market on Wednesday it has completed its £256 million ($387 million) acquisition of Alfa Aesar. The deal was announced in June. Based in Heysham, UK,..

Veritas Genetics recently announced it is partnering with the Personal Genome Project (PGP) to offer whole-genome sequencing and interpretation for less than $1,000. Veritas said in a statement that the collaborat..